# Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer

> **NCT06018883** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Fudan University** · enrollment: 100 (estimated)

## Conditions studied

- Metastatic Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** Ascorbate
- **DRUG:** Nab paclitaxel
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT06018883
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-20
- **Primary completion:** 2025-08-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06018883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06018883, "Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06018883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*